title: Rheumatoid arthritis decision making: many information sources but not all rated as useful.
abstract: BACKGROUND
  Patients who make high-quality medical decisions are more likely to have better health outcomes. One of the central components to a high-quality decision is the well-informed manner in which it is made. However, there has been little research studying patient behaviors regarding how they seek information about treatments for rheumatoid arthritis (RA).
  
  
  METHODS
  We conducted a pilot study surveying beneficiaries of a health plan who had 2 or more visits coded for RA. Of 799 invited subjects, 101 (13%) completed interviews. Participants answered a questionnaire regarding sources of RA treatment information and their usefulness, sociodemographic items, and scales regarding their attitudes toward providers and medicines. Outcomes of interest included the average number of sources described (range, 0-10) and the usefulness for each source (1 "not useful" and 4 "extremely useful").
  
  
  RESULTS
  Methotrexate was the most widely used medication reported. The mean (SD) number of information sources used was 5.0 (2.1). Participants rated the information they used with a mean (SD) score of 2.8 (0.7). We found no strong patient correlates of these outcomes when compared with the aforementioned domains. Of the 98% of the total sample who referred to a rheumatologist for information, 87% rated the source as extremely useful. The Internet was the most frequently used nonprovider source, with 63% of subjects reporting use, and a mean (SD) usefulness rating of 3.0 (1.03).
  
  
  CONCLUSIONS
  In this pilot study, participants used many sources of information regarding treatment decisions for RA. Ninety-eight percent of the participants used rheumatologists as a source and found them extremely useful. Of the nonprovider sources, the Internet was most common, and 40% found it very useful.
authors.affiliation: Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, USA.
authors.forename: Katie
authors.initials: K
authors.lastname: Garneau
authors.forename: Maura
authors.initials: M
authors.lastname: Iversen
authors.forename: Saira
authors.initials: S
authors.lastname: Jan
authors.forename: Kavita
authors.initials: K
authors.lastname: Parmar
authors.forename: Peter
authors.initials: P
authors.lastname: Tsao
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Solomon
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003625:Data Collection; D003657:Decision Making; D005260:Female; D006801:Humans; D007255:Information Services / Q000639:trends*; D020407:Internet; D007407:Interviews as Topic; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010353:Patient Education as Topic / Q000379:methods; D010358:Patient Participation / Q000639:trends*; D010817:Physician-Patient Relations; D010865:Pilot Projects
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate